» Articles » PMID: 24126629

The Epidemiology of ALS: a Conspiracy of Genes, Environment and Time

Overview
Journal Nat Rev Neurol
Specialty Neurology
Date 2013 Oct 16
PMID 24126629
Citations 369
Authors
Affiliations
Soon will be listed here.
Abstract

Amyotrophic lateral sclerosis (ALS) is a relentlessly progressive neurodegenerative disease of motor neurons, resulting in worsening weakness of voluntary muscles until death from respiratory failure occurs after about 3 years. Although great advances have been made in our understanding of the genetic causes of ALS, the contribution of environmental factors has been more difficult to assess. Large-scale studies of the clinical patterns of ALS, individual histories preceding the onset of ALS, and the rates of ALS in different populations and groups have led to improved patient care, but have not yet revealed a replicable, definitive environmental risk factor. In this Review, we outline what is currently known of the environmental and genetic epidemiology of ALS, describe the current state of the art with respect to the different types of ALS, and explore whether ALS should be considered a single disease or a syndrome. We examine the relationship between genetic and environmental risk factors, and propose a disease model in which ALS is considered to be the result of environmental risks and time acting on a pre-existing genetic load, followed by an automatic, self-perpetuating decline to death.

Citing Articles

Derivation of functional neurons from induced pluripotent stem cells using a simple neuromesodermal progenitor generation and rapid spinal cord neuron differentiation process.

Senkal-Turhan S, Bulut-Okumus E, Sahin F, Yavuz Y, Yilmaz B, Sisli H Hum Cell. 2025; 38(3):69.

PMID: 40080267 DOI: 10.1007/s13577-025-01200-3.


Mechanisms underlining R-loop biology and implications for human disease.

Liu J, Li F, Cao Y, Lv Y, Lei K, Tu Z Front Cell Dev Biol. 2025; 13:1537731.

PMID: 40061014 PMC: 11885306. DOI: 10.3389/fcell.2025.1537731.


Epigenetic regulation of TDP-43: potential implications for amyotrophic lateral sclerosis.

Mengistu D, Terribili M, Pellacani C, Ciapponi L, Marzullo M Front Mol Med. 2025; 5:1530719.

PMID: 40017539 PMC: 11865237. DOI: 10.3389/fmmed.2025.1530719.


Genetic evidence for the liver-brain axis: lipid metabolism and neurodegenerative disease risk.

Wang Z, Yin Z, Sun G, Zhang D, Zhang J Lipids Health Dis. 2025; 24(1):41.

PMID: 39923073 PMC: 11806572. DOI: 10.1186/s12944-025-02455-3.


MEPs and MRI Motor Band Sign as Potential Complementary Markers of Upper Motor Neuron Involvement in Amyotrophic Lateral Sclerosis.

Calvi F, Fortuna A, Bello L, Anglani M, Cecchin D, Sabbatini D Eur J Neurol. 2025; 32(2):e70055.

PMID: 39916336 PMC: 11802645. DOI: 10.1111/ene.70055.


References
1.
Donaghy C, OToole O, Sheehan C, Kee F, Hardiman O, Patterson V . An all-Ireland epidemiological study of MND, 2004-2005. Eur J Neurol. 2008; 16(1):148-53. DOI: 10.1111/j.1468-1331.2008.02361.x. View

2.
Barth S, Kang H, Bullman T, Wallin M . Neurological mortality among U.S. veterans of the Persian Gulf War: 13-year follow-up. Am J Ind Med. 2009; 52(9):663-70. DOI: 10.1002/ajim.20718. View

3.
Van den Berg-Vos R, Visser J, Kalmijn S, Fischer K, de Visser M, de Jong V . A long-term prospective study of the natural course of sporadic adult-onset lower motor neuron syndromes. Arch Neurol. 2009; 66(6):751-7. DOI: 10.1001/archneurol.2009.91. View

4.
Arnold A, EDGREN D, Palladino V . Amyotrophic lateral sclerosis; fifty cases observed on Guam. J Nerv Ment Dis. 1953; 117(2):135-9. View

5.
Roche J, Rojas-Garcia R, Scott K, Scotton W, Ellis C, Burman R . A proposed staging system for amyotrophic lateral sclerosis. Brain. 2012; 135(Pt 3):847-52. PMC: 3286327. DOI: 10.1093/brain/awr351. View